TechCN

MacroGenics Announces Sale of TZIELD™ Royalty Interest for

ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and......